Ibnsina Pharma (EGX:ISPH)

Market Cap	10.10B
Revenue (ttm)	62.31B
Net Income (ttm)	565.62M
Shares Out	1.01B
EPS (ttm)	0.56
PE Ratio	17.86
Forward PE	8.80
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,017,660
Average Volume	6,544,891
Open	9.95
Previous Close	9.95
Day's Range	9.92 - 10.05
52-Week Range	2.52 - 10.47
Beta	0.50
RSI	57.34
Earnings Date	Aug 13, 2025

About AY

Ibnsina Pharma operates as a pharmaceutical distributor in Egypt. The company offers pharmaceutical and cosmetics products to private and public-sector customers, including retail chains, independent pharmacies, wholesalers, hospitals, and healthcare institutions. It also provides warehousing and logistic services for its suppliers; marketing solutions; importation and packaging services; and market research and analysis services, as well as value added services. The company was founded in 2001 and is headquartered in El Obour City, Egypt.

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 2001
• Employees: 5,500
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: ISPH

Financial Performance

In 2024, Ibnsina Pharma's revenue was 55.84 billion, an increase of 64.49% compared to the previous year's 33.95 billion. Earnings were 497.80 million, an increase of 187.51%.